These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23011508)

  • 1. Comparing attendees with non-attendees in breast screening does not provide useful information about an effect on prognostic features or mortality.
    Jørgensen KJ; Kalager M; Zahl PH; Fønnebø VM
    Breast Cancer Res Treat; 2012 Nov; 136(2):617-8, author reply 619-20. PubMed ID: 23011508
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Detection of ductal carcinoma in situ in women undergoing screening mammography.
    Kopans DB
    J Natl Cancer Inst; 2003 Mar; 95(6):487; author reply 487-8. PubMed ID: 12644544
    [No Abstract]   [Full Text] [Related]  

  • 3. Projecting the benefits and harms of mammography using statistical models: proof or proofiness?
    Kramer BS; Elmore JG
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25925581
    [No Abstract]   [Full Text] [Related]  

  • 4. Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality.
    Barratt A
    BMJ; 2015 Mar; 350():h867. PubMed ID: 25736426
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening mammography after autologous breast reconstruction is not beneficial.
    Barton MK
    CA Cancer J Clin; 2015; 65(1):3-4. PubMed ID: 25533748
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimizing Mammography Screening Intervals.
    Yi M; Hunt KK
    JAMA; 2015 Oct; 314(15):1635-6. PubMed ID: 26501538
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing invasive breast cancer: another benefit from mammographic screening.
    Cady B; Chung MA
    Cancer; 2011 Jul; 117(14):3064-8. PubMed ID: 21246518
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mammography in breast cancer].
    Zal'tsman IN
    Med Radiol (Mosk); 1972 Jul; 17(7):23-8. PubMed ID: 4351234
    [No Abstract]   [Full Text] [Related]  

  • 10. Measuring the Effectiveness of Mammography.
    Chen WY
    JAMA Oncol; 2015 Nov; 1(8):1037-8. PubMed ID: 26501739
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of mammography as a mass-screening technic in tumor detection. 1st results in 1080 examined women].
    Scherer E; Seifert J
    Fortschr Geb Rontgenstr Nuklearmed; 1968 Dec; 109(6):766-70. PubMed ID: 4303575
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast cancer screening.
    Milbrath JR; Moskowitz M; Bauermeister D
    Crit Rev Diagn Imaging; 1981; 16(3):181-218. PubMed ID: 6268356
    [No Abstract]   [Full Text] [Related]  

  • 13. Does breast screening offer a survival benefit? A retrospective comparative study of oncological outcomes of screen-detected and symptomatic early stage breast cancer cases.
    Újhelyi M; Pukancsik D; Kelemen P; Kovács E; Kenessey I; Udvarhelyi N; Bak M; Kovács T; Mátrai Z
    Eur J Surg Oncol; 2016 Dec; 42(12):1814-1820. PubMed ID: 27424787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
    Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
    Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [X-ray diagnosis of non-palpable breast cancer and limited non-cancerous breast diseases].
    Zal'tsman IN
    Med Radiol (Mosk); 1984 Aug; 29(8):79-86. PubMed ID: 6088937
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mammography].
    Fischer U
    MMW Fortschr Med; 2003 Sep; 145(37):66-7. PubMed ID: 14584453
    [No Abstract]   [Full Text] [Related]  

  • 18. Should we undertake an MRI breast screening trial?
    Thorat MA
    Lancet; 2007 Dec; 370(9603):1902; author reply 1903-4. PubMed ID: 18068505
    [No Abstract]   [Full Text] [Related]  

  • 19. [The interval carcinoma in periodic breast screening, a new concept].
    Wobbes T; Hendriks JH
    Ned Tijdschr Geneeskd; 1989 Nov; 133(45):2209-12. PubMed ID: 2554158
    [No Abstract]   [Full Text] [Related]  

  • 20. Should we undertake an MRI breast screening trial?
    Thornton H
    Lancet; 2007 Dec; 370(9603):1903; author reply 1903-4. PubMed ID: 18068507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.